Artery Research
Volume 2, Issue 2 , Pages 60-66 , May 2008

The effects of central arterial pressure and autonomic dysfunction on elevations in N-terminal pro-B-type natriuretic peptide (NT-proBNP) in men with diabetes

  • S. Bunce

      Affiliations

    • Department of Medicine, Torbay Hospital, Devon, TQ2 7AA, UK
  • ,
  • A. Stride

      Affiliations

    • Department of Medicine, Torbay Hospital, Devon, TQ2 7AA, UK
  • ,
  • C. Matthews

      Affiliations

    • Department of Medicine, Torbay Hospital, Devon, TQ2 7AA, UK
  • ,
  • S. Shaw

      Affiliations

    • School of Mathematics and Statistics, University of Plymouth, PL4 8AA, UK
  • ,
  • J.C. Smith

      Affiliations

    • Department of Medicine, Torbay Hospital, Devon, TQ2 7AA, UK
    • Corresponding Author InformationCorresponding author. Department of Diabetes & Endocrinology, Torbay Hospital, Lawes Bridge, Torquay, TQ2 7AA, UK. Tel.:+44 01803 654923; fax: +44 01803 655741.

Received 9 November 2007 ,Revised 12 March 2008 ,Accepted 17 March 2008.

References 

  1. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213–3223
  2. Debono M, Cachia E. The impact of cardiovascular autonomic neuropathy in diabetes: is it associated with left ventricular dysfunction?. Auton Neurosci. 2007;132:1–7
  3. Wilkinson IB, MacCallum H, Rooijmans DF, Murray GD, Cockcroft JR, McKnight JA, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441–448
  4. Tentolouris N, Liatis S, Moyssakis I, Tsapogas P, Psallas M, Diakoumopoulou E, et al. Aortic distensibility is reduced in subjects with type 2 diabetes and cardiac autonomic neuropathy. Eur J Clin Invest. 2003;33:1075–1083
  5. Meyer C, Milat F, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ. Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet Med. 2004;21:746–751
  6. Saba PS, Roman MJ, Pini R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873–1880
  7. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure?. Ann Clin Biochem. 2001;38:575–583
  8. Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet. 2002;359:1430–1432
  9. Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996;93:1963–1969
  10. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913–2918
  11. Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus. Diabet Med. 2005;22:188–195
  12. Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, et al. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens. 2006;19:443–447
  13. Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation. 2007;115:3079–3085
  14. Sakuragi S, Okawa K, Iwasaki J, Tokunaga N, Kakishita M, Ohe T. Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease. Cardiology. 2007;107:140–146
  15. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002;106:2085–2090
  16. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens. 1996;14(suppl 5):S147–S157
  17. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–937
  18. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16:2079–2084
  19. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: comparison of measures of R–R interval variation. Diabetologia. 1981;21:18–24
  20. Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, et al. Abnormal cardiovascular reflex tests are predictors of mortality in Type 2 diabetes mellitus. Diabet Med. 2001;18:268–273
  21. Dawson A, Davies JI, Morris AD, Struthers AD. B-type natriuretic peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure. Am J Hypertens. 2005;18:1586–1591
  22. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev. 2003;24:341–356
  23. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327–337
  24. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281:634–639
  25. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206
  26. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int. 2003;63:1852–1860
  27. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–1579
  28. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–1961
  29. Ahlgren AR, Sundkvist G, Wollmer P, Sonesson B, Lanne T. Increased aortic stiffness in women with type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function. Diabet Med. 1999;16:291–297
  30. Thomas CJ, Head GA, Woods RL. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats. J Hypertens. 1999;17:801–806
  31. Yufu K, Takahashi N, Nakagawa M, Hara M, Saikawa T, Yoshimatsu H. Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients. Diabetes Res Clin Pract. 2006;72:12–19

PII: S1872-9312(08)00029-X

doi: 10.1016/j.artres.2008.03.002

Artery Research
Volume 2, Issue 2 , Pages 60-66 , May 2008